AOR (95% CI) (n=820b) | |
---|---|
Age group, years | |
18–24 | Reference |
25–34 | 0.72 (0.45, 1.14) |
35–49+ | 0.65 (0.36, 1.17) |
Education level | |
None | Reference |
Primary/middle | 1.04 (0.67, 1.61) |
Secondary or higher | 0.74 (0.44, 1.24) |
Religion | |
Christian | Reference |
Muslim | 1.51 (0.69, 3.30) |
Parity | |
0 | Reference |
1–2 | 0.56 (0.19, 1.66) |
3–4 | 0.41 (0.13, 1.28) |
5+ | 0.34 (0.10, 1.19) |
Fertility intentions | |
Do not want more children/do not want to have children/unsure | Reference |
Want more children/want to have children | 1.24 (0.76, 2.04) |
Wealth (urban score) | |
Low (quintile 1–3) | Reference |
Middle (quintile 4) | 0.89 (0.57, 1.40) |
High (quintile 5) | 1.03 (0.68, 1.56) |
Previous use of current method | 0.74 (0.50, 1.11) |
Partner knowledge of current method at time of insertion | 1.18 (0.74, 1.89) |
Informed choice | 1.42 (1.03, 1.96)c |
Received method wanted | 0.81 (0.45, 1.44) |
Insertion was free | 0.76 (0.54, 1.07) |
Informed method could be removed at any time | 1.00 (0.55, 1.81) |
Experienced amenorrhea | 1.61 (1.12, 2.32)c |
Experienced bleeding disturbances | 1.13 (0.81, 1.56) |
Experienced shorter or reduced bleeding | 0.55 (0.33, 0.91)c |
Experienced longer or heavier bleeding | 1.23 (0.87, 1.75) |
Experienced weight gain | 0.94 (0.68, 1.30) |
Experienced other side effectsd | 2.61 (1.89, 3.60)c |
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.
↵a Data are from phone and in-person survey participants. Nonresponses varied across items; small amounts of data are missing.
↵b Sample size of implant users (n=1,362) is reduced to n=820 in the multivariable regression model due to missing data.
↵c Statistically significant (P≤.05).
↵d Other side effects include any mentioned non-bleeding side effects other than weight gain.